United Therapeutics buy tamam
Start price
31.08.17
/
50%
€116.65
Target price
03.06.19
€150.63
Performance (%)
-35.27%
End price
03.06.19
€75.51
Summary
This prediction ended on 03.06.19 with a price of €75.51. The BUY prediction by tamam for United Therapeutics performed very badly with a performance of -35.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| United Therapeutics | 2.397% | 2.397% | 42.760% | 87.771% |
| iShares Core DAX® | 1.454% | 0.904% | 16.592% | 16.557% |
| iShares Nasdaq 100 | -0.913% | 3.463% | 36.062% | 50.205% |
| iShares Nikkei 225® | 2.355% | 3.830% | 14.881% | 10.110% |
| iShares S&P 500 | 0.283% | 2.639% | 29.599% | 44.509% |
Comments by tamam for this prediction
In the thread United Therapeutics diskutieren
tamam stimmt dem Crowdsentiment von 'Buy' zu
tamam stimmt am 31.08.2017 dem Buy-Crowdsentiment mit dem Kursziel 167.0$ zu.
Eine Kurserholung drängt sich auf, da die
FDA rejects SteayMed's marketing application for lead candidate Trevyent for PAH!
(Vom Mitglied beendet)